Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 294

    1.

    Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.

    Boumpas DT, Austin HA 3rd, Vaughan EM, Yarboro CH, Klippel JH, Balow JE.

    Ann Intern Med. 1993 Sep 1;119(5):366-9.PMID: 8338289 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus.

    Ioannidis JP, Katsifis GE, Tzioufas AG, Moutsopoulos HM.

    J Rheumatol. 2002 Oct;29(10):2129-35.PMID: 12375322 [PubMed - indexed for MEDLINE]Related articles

    3.

    [The risk of sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy]

    Liu G, Chen Y, Wang L, Zuo C, Xie Q, Wang Z, Lin M.

    Hua Xi Yi Ke Da Xue Xue Bao. 2001 Jun;32(2):294-5, 306. Chinese. PMID: 12600113 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ovarian failure in SLE patients using pulse cyclophosphamide: comparison of different regimes.

    Appenzeller S, Blatyta PF, Costallat LT.

    Rheumatol Int. 2008 Apr;28(6):567-71. Epub 2007 Oct 30.PMID: 17968551 [PubMed - indexed for MEDLINE]Related articles

    5.

    Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.

    Huong DL, Amoura Z, Duhaut P, Sbai A, Costedoat N, Wechsler B, Piette JC.

    J Rheumatol. 2002 Dec;29(12):2571-6.PMID: 12465154 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children]

    Hu J, Li CW, Zhang X, Pi SH, Zhao JS, Chen XY, Liu Y.

    Zhonghua Er Ke Za Zhi. 2003 Jun;41(6):430-4. Chinese. PMID: 14748998 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ]

    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.

    Srp Arh Celok Lek. 2002 Aug;130 Suppl 3:19-25. Serbian. PMID: 12583309 [PubMed - indexed for MEDLINE]Related articles

    8.

    Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide.

    Katsifis GE, Tzioufas AG.

    Lupus. 2004;13(9):673-8. Review.PMID: 15485101 [PubMed - indexed for MEDLINE]Related articles

    9.

    Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.

    Gourley MF, Austin HA 3rd, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD.

    Ann Intern Med. 1996 Oct 1;125(7):549-57.PMID: 8815753 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

    Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT.

    Ann Intern Med. 2001 Aug 21;135(4):248-57.PMID: 11511139 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy.

    Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M.

    Lupus. 2000;9(6):401-5.PMID: 10981642 [PubMed - indexed for MEDLINE]Related articles

    12.

    Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus.

    Wang CL, Wang F, Bosco JJ.

    Lupus. 1995 Feb;4(1):11-4.PMID: 7767332 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus.

    Boumpas DT, Barez S, Klippel JH, Balow JE.

    Ann Intern Med. 1990 May 1;112(9):674-7.PMID: 2334081 [PubMed - indexed for MEDLINE]Related articles

    14.

    Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy.

    Opastirakul S, Chartapisak W.

    Pediatr Nephrol. 2005 Dec;20(12):1750-5. Epub 2005 Aug 24.PMID: 16133037 [PubMed - indexed for MEDLINE]Related articles

    15.

    Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy.

    Park MC, Park YB, Jung SY, Chung IH, Choi KH, Lee SK.

    Lupus. 2004;13(8):569-74.PMID: 15462485 [PubMed - indexed for MEDLINE]Related articles

    16.

    Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.

    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.

    Am J Med. 2006 Apr;119(4):355.e25-33.PMID: 16564783 [PubMed - indexed for MEDLINE]Related articles

    17.

    Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.

    Austin HA 3rd, Patel AD, Cadena CA, Boumpas DT, Balow JE.

    J Rheumatol. 1997 Jan;24(1):61-8.PMID: 9002012 [PubMed - indexed for MEDLINE]Related articles

    18.

    Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.

    Contreras G, Tozman E, Nahar N, Metz D.

    Lupus. 2005;14 Suppl 1:s33-8.PMID: 15803929 [PubMed - indexed for MEDLINE]Related articles

    19.

    Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy.

    Mok CC, Lau CS, Wong RW.

    Arthritis Rheum. 1998 May;41(5):831-7.PMID: 9588734 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

    Boumpas DT, Austin HA 3rd, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE.

    Lancet. 1992 Sep 26;340(8822):741-5.PMID: 1356175 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data